Dosing of Vancomycin in Patients with Continuous-Flow Left Ventricular Assist Devices: A Clinical Pharmacokinetic Analysis

No abstract is available for this paper.

• Publication year

  2014

• Venue

  International Journal of Artificial Organs

• Publication date

  2014-01-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.5301/ijao.5000285PMID 24619894
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients.

  2013cited by this paper
• Decreased vancomycin clearance in patients with congestive heart failure

  2012cited by this paper
• Continuous-flow devices and percutaneous site infections: clinical outcomes.

  2012cited by this paper
• Infectious complications after pulsatile-flow and continuous-flow left ventricular assist device implantation.

  2011cited by this paper
• Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era.

  2010cited by this paper
• Renal and Hepatic Function Improve in Advanced Heart Failure Patients During Continuous-Flow Support With the HeartMate II Left Ventricular Assist Device

  2009cited by this paper
• Pharmacokinetics of R- and S-carvedilol in routinely treated Japanese patients with heart failure.

  2008cited by this paper
• Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury

  2007cited by this paper
• Effect of congestive heart failure on mexiletine pharmacokinetics in a Japanese population.

  2006cited by this paper
• Antimicrobial dosing in obese patients.

  1997cited by this paper
• Application of population pharmacokinetics to the optimization of theophylline therapy

  1996cited by this paper
• Vancomycin Pharmacokinetics in a Patient Population: Effect of Age, Gender, and Body Weight

  1994cited by this paper
• The pharmacokinetics of midazolam in patients with congestive heart failure.

  1990cited by this paper
• Individualizing vancomycin dosage regimens: one- versus two-compartment Bayesian models.

  1989cited by this paper
• Clinical pharmacokinetics in heart failure. An updated review.

  1988cited by this paper
• Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass.

  1988cited by this paper
• Pharmacokinetics and pharmacodynamics of antiarrhythmic agents in patients with congestive heart failure.

  1987cited by this paper
• Kinetic model for gentamicin dosing with the use of individual patient parameters

  1977cited by this paper
• Prediction of Creatinine Clearance from Serum Creatinine

  1976cited by this paper
• Prediction of creatinine clearance from serum creatinine.

  1975cited by this paper

• Association between the difference in creatinine-based and creatinine-cystatin C-based estimated glomerular filtration rates and vancomycin systemic exposure after ventricular assist device surgery

  2025cites this paper
• The pharmacokinetics of antibiotics in patients with obesity: a systematic review and consensus guidelines for dose adjustments.

  2025cites this paper
• Bring it on: Top five antimicrobial stewardship challenges in transplant infectious diseases and practical strategies to address them

  2022cites this paper
• The Future of Cardiothoracic Surgical Critical Care Medicine as a Medical Science: A Call to Action

  2022cites this paper
• Evaluation of a hospital-wide vancomycin-dosing nomogram in patients with continuous-flow left ventricular assist devices

  2020cites this paper
• Contemporary Management Strategies in VAD Infection

  2020cites this paper
• Advanced Heart Failure : Mechanical Circulatory Support and Heart Transplantation

  2019cites this paper
• Pharmacotherapy considerations for long‐term management of patients with left ventricular assist devices

  2018cites this paper
• Clinical pharmacology considerations for children supported with ventricular assist devices

  2018cites this paper
• Lidocaine toxicity in the setting of HeartMate II left ventricular assist device

  2018cites this paper